Ausgabe 2/2008
Inhalt (17 Artikel)
Full-field digital mammography compared with screen-film mammography in the detection of breast cancer: rays of light through DMIST or more fog?
Jeffrey A. Tice, Mitchell D. Feldman
Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy
David Cella, Lesley J. Fallowfield
Insulin-like growth factor binding proteins and breast cancer
Ashok Subramanian, Anup Sharma, Kefah Mokbel
SUMO and estrogen receptors in breast cancer
Michalis V. Karamouzis, Panagiotis A. Konstantinopoulos, Filitsa A. Badra, Athanasios G. Papavassiliou
Prophylactic IL-12 treatment reduces postoperative metastasis: mediation by increased numbers but not cytotoxicity of NK cells
Yossi Schwartz, Roi Avraham, Marganit Benish, Ella Rosenne, Shamgar Ben-Eliyahu
Exploring the two-gene ratio in breast cancer—independent roles for HOXB13 and IL17BR in prediction of clinical outcome
Piiha-Lotta Jerevall, Sara Brommesson, Carina Strand, Sofia Gruvberger-Saal, Per Malmström, Bo Nordenskjöld, Sten Wingren, Peter Söderkvist, Mårten Fernö, Olle Stål
EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor
Clara Hwang, Veda N. Giri, John C. Wilkinson, Casey W. Wright, Amanda S. Wilkinson, Kathleen A. Cooney, Colin S. Duckett
The spectrum of ATM missense variants and their contribution to contralateral breast cancer
Annegien Broeks, Linde M. Braaf, Angelina Huseinovic, Marjanka K. Schmidt, Nicola S. Russell, Flora E. van Leeuwen, Frans B. L. Hogervorst, Laura J. Van ‘t Veer
Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases
Ashish B. Rajput, Dmitry A. Turbin, Maggie CU Cheang, David K. Voduc, Sam Leung, Karen A. Gelmon, C. Blake Gilks, David G. Huntsman
Correlation of levels and patterns of genomic instability with histological grading of invasive breast tumors
Rachel E. Ellsworth, Jeffrey A. Hooke, Brad Love, Jennifer L. Kane, Heather L. Patney, Darrell L. Ellsworth, Craig D. Shriver
Diminished feedback regulation of proteasome expression and resistance to proteasome inhibitors in breast cancer cells
Haiming Xu, Donghong Ju, Tiffany Jarois, Youming Xie
Impact of chemotherapy beyond the first line in patients with metastatic breast cancer
Armelle Dufresne, Xavier Pivot, Christophe Tournigand, Thomas Facchini, Thierry Altweegg, Loic Chaigneau, Aimery De Gramont
ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences?
Teresa Tapia, Alejandro Sanchez, Maricarmen Vallejos, Carolina Alvarez, Mauricio Moraga, Susan Smalley, Mauricio Camus, Manuel Alvarez, Pilar Carvallo
A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk
Claire E. Wakefield, Bettina Meiser, Judi Homewood, Michelle Peate, Alan Taylor, Elizabeth Lobb, Judy Kirk, Mary-Anne Young, Rachel Williams, Tracy Dudding, Kathy Tucker
Dasatinib may also inhibit c-Kit in triple negative breast cancer cell lines
Omer Dizdar, Didem S. Dede, Nilufer Bulut, Kadri Altundag
Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women
Martha L. Slattery, Carol Sweeney, Sandra Edwards, Jennifer Herrick, Kathy Baumgartner, Roger Wolff, Maureen Murtaugh, Richard Baumgartner, Anna Giuliano, Tim Byers
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study
Agnés Fournier, Franco Berrino, Françoise Clavel-Chapelon